Hideko Murooka
Kyowa Kirin (Japan)(JP)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Bone health and treatments, Inflammatory mediators and NSAID effects, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research
Most-Cited Works
- → Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors(2003)398 cited
- → Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of N-Phenyl-N‘-{4-(4-quinolyloxy)phenyl}ureas(2005)144 cited
- → A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model(2006)99 cited
- → The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse model(2007)63 cited
- → The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis(2008)31 cited
- → Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors(2004)25 cited
- → Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis(1998)23 cited
- → Synthesis and structure–activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase(2003)22 cited
- → A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation(1997)18 cited
- Synthesis and structure-activity relationship of Quinazoline-Urea derivatives as novel orally active VEGF receptor tyrosine kinase selective inhibitors(2002)